Navigation auf zora.uzh.ch

Search ZORA

ZORA (Zurich Open Repository and Archive)

Automated light-induced synthesis of 89Zr-radiolabeled antibodies for immuno-positron emission tomography

Klingler, Simon; Holland, Jason P (2022). Automated light-induced synthesis of 89Zr-radiolabeled antibodies for immuno-positron emission tomography. Scientific Reports, 12:668.

Abstract

Clinical production of 89Zr-radiolabeled antibodies (89Zr-mAbs) for positron emission tomography imaging relies on the pre-conjugation of desferrioxamine B (DFO) to the purified protein, followed by isolation and characterization of the functionalized intermediate, and then manual radiosynthesis. Although highly successful, this route exposes radiochemists to a potentially large radiation dose and entails several technological and economic hurdles that limit access of 89Zr-mAbs to just a specialist few Nuclear Medicine facilities worldwide. Here, we introduce a fully automated synthesis box that can produce individual doses of 89Zr-mAbs formulated in sterile solution in < 25 min starting from [89Zr(C2O4)4]4- (89Zr-oxalate), our good laboratory practice-compliant photoactivatable desferrioxamine-based chelate (DFO-PEG3-ArN3), and clinical-grade antibodies without the need for pre-purification of protein. The automated steps include neutralization of the 89Zr-oxalate stock, chelate radiolabeling, and light-induced protein conjugation, followed by 89Zr-mAb purification, formulation, and sterile filtration. As proof-of-principle, 89ZrDFO-PEG3-azepin-trastuzumab was synthesized directly from Herceptin in < 25 min with an overall decay-corrected radiochemical yield of 20.1 ± 2.4% (n = 3), a radiochemical purity > 99%, and chemical purity > 99%. The synthesis unit can also produce 89Zr-mAbs via the conventional radiolabeling routes from pre-functionalized DFO-mAbs that are currently used in the clinic. This automated method will improve access to state-of-the-art 89Zr-mAbs at the many Nuclear Medicine and research institutions that require automated devices for radiotracer production.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:07 Faculty of Science > Department of Chemistry
Dewey Decimal Classification:540 Chemistry
Scopus Subject Areas:Health Sciences > Multidisciplinary
Uncontrolled Keywords:Multidisciplinary
Language:English
Date:13 January 2022
Deposited On:05 Jan 2023 09:30
Last Modified:28 Oct 2024 02:40
Publisher:Nature Publishing Group
ISSN:2045-2322
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1038/s41598-021-04626-5
PubMed ID:35027637
Project Information:
  • Funder: Swiss National Science Foundation
  • Grant ID: PP00P2_163683
  • Project Title:
  • Funder: Swiss National Science Foundation
  • Grant ID: PP00P2_190093
  • Project Title:
  • Funder: Swiss Cancer Research Foundation
  • Grant ID: KFS-4257-08-2017
  • Project Title:
  • Funder: H2020
  • Grant ID: 676904
  • Project Title: Developing multi-modality nanomedicines for targeted annotation of oncogenic signaling pathways
  • Funder: H2020
  • Grant ID: 101001734
  • Project Title: Light-induced synthesis of protein-drug conjugates for imaging and therapy
Download PDF  'Automated light-induced synthesis of 89Zr-radiolabeled antibodies for immuno-positron emission tomography'.
Preview
  • Content: Published Version
  • Language: English
  • Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
5 citations in Web of Science®
4 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

46 downloads since deposited on 05 Jan 2023
33 downloads since 12 months
Detailed statistics

Authors, Affiliations, Collaborations

Similar Publications